Your browser doesn't support javascript.
loading
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer.
Giani, Carlotta; Valerio, Laura; Bongiovanni, Alberto; Durante, Cosimo; Grani, Giorgio; Ibrahim, Toni; Mariotti, Stefano; Massa, Michela; Pani, Fabiana; Pellegriti, Gabriella; Porcelli, Tommaso; Salvatore, Domenico; Tavarelli, Martina; Torlontano, Massimo; Locati, Laura; Molinaro, Eleonora; Elisei, Rossella.
Affiliation
  • Giani C; Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Valerio L; Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Bongiovanni A; Osteoncology and Rare Tumors Center Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST, IRCCS, Meldola, Italy.
  • Durante C; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Grani G; Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy.
  • Ibrahim T; Osteoncology and Rare Tumors Center Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori IRST, IRCCS, Meldola, Italy.
  • Mariotti S; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Massa M; Department of Medical Science, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Pani F; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy.
  • Pellegriti G; Endocrinology Division, Garibaldy Nesima Hospital, Catania, Italy.
  • Porcelli T; Department of Public Health, University of Naples "Federico II," Naples, Italy.
  • Salvatore D; Department of Public Health, University of Naples "Federico II," Naples, Italy.
  • Tavarelli M; Endocrinology Division, Garibaldy Nesima Hospital, Catania, Italy.
  • Torlontano M; Department of Medical Science, Fondazione IRCCS Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Locati L; Head and Neck Cancer Medical Oncology Unit, Fondazione IRCCS "Istituto Nazionale dei Tumori," Milan, Italy.
  • Molinaro E; Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Elisei R; Endocrinology Unit, Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
Thyroid ; 31(2): 224-232, 2021 02.
Article in En | MEDLINE | ID: mdl-32907501
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quality of Life / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors / Health Services Accessibility / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Thyroid Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quality of Life / Quinolines / Thyroid Neoplasms / Protein Kinase Inhibitors / Health Services Accessibility / Antineoplastic Agents Type of study: Clinical_trials / Diagnostic_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Aspects: Determinantes_sociais_saude / Patient_preference Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Country/Region as subject: Europa Language: En Journal: Thyroid Journal subject: ENDOCRINOLOGIA Year: 2021 Document type: Article Affiliation country: Italy Country of publication: United States